GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savior Lifetec Corp (ROCO:4167) » Definitions » Purchase Of Investment

Savior Lifetec (ROCO:4167) Purchase Of Investment : NT$-809 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Savior Lifetec Purchase Of Investment?

Savior Lifetec's purchase of investment for the three months ended in Mar. 2025 was NT$-20 Mil. It means Savior Lifetec spent NT$20 Mil on purchasing investments. Savior Lifetec's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-809 Mil.

Compared with last quarter (NT$-420 Mil in Dec. 2024 ), Savior Lifetec spent less money on purchasing investments in Mar. 2025 (NT$-20 Mil).

Savior Lifetec Purchase Of Investment Historical Data

The historical data trend for Savior Lifetec's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savior Lifetec Purchase Of Investment Chart

Savior Lifetec Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -95.22 - -294.70 -212.61 -891.88

Savior Lifetec Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -103.06 -100.00 -269.13 -419.70 -20.06

Savior Lifetec Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-809 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Savior Lifetec Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Savior Lifetec's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Savior Lifetec Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Savior Lifetec Corp (ROCO:4167) » Definitions » Purchase Of Investment
Comparable Companies
ROCO:7759 ROCO:7832 ROCO:4157 TPE:6657 TPE:1760 ROCO:6875 TPE:6949 TPE:1734 TPE:4142 ROCO:4726 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 29, Kezhong Road, Hsinchu Science Park, Zhunan Township, Miaoli, TWN, 350
Website
https://www.saviorlifetec.com.tw
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions such as the Americas, Asia, Taiwan, and Europe.

Savior Lifetec Headlines

No Headlines